作者: Thomas D. Wang , Bishnu P. Joshi , Juan Zho
DOI:
关键词:
摘要: The present invention is directed to EGFR-specific peptide reagents, methods for detecting pre-cancer, early cancer and/or using the and targeting pre-cancer cells, cells reagents. In one aspect, disclosure provides reagents consisting essentially of a QRHKPRE (SEQ ID NO: 1), HAHRSWS 2), YLTMPTP 3), TYPISFM 4), KLPGWSG 5), IQSPHFF 6), YSIPKSS 7), SHRNRPRNTQPS 8), NRHKPREKTFTD 9).